Quick Facts
What is BPC-157?
BPC-157 is a synthetic pentadecapeptide consisting of 15 amino acids. It is derived from a protective protein found in the stomach, where it plays a role in maintaining gut integrity and promoting healing. Research has demonstrated remarkable regenerative properties across multiple tissue types, making it one of the most studied peptides in the regenerative medicine field. The compound works through multiple mechanisms including angiogenesis promotion, growth factor modulation, and nitric oxide system regulation.
How Does BPC-157 Work?
BPC-157 exerts its effects through several interconnected pathways. It upregulates growth hormone receptors, promotes angiogenesis (new blood vessel formation), and modulates the nitric oxide system. The peptide interacts with the dopaminergic and GABAergic systems, contributing to its systemic effects. Research suggests it may also influence the FAK-paxillin pathway, which is crucial for cell migration and tissue repair. Additionally, BPC-157 has been shown to counteract the effects of NSAIDs on the gastrointestinal tract and may protect against various toxic insults.
Research-Backed Benefits
Accelerated Tissue Repair
Strong EvidencePromotes healing of tendons, ligaments, muscles, and bone tissue through enhanced collagen synthesis and angiogenesis.
Gastrointestinal Protection
Strong EvidenceSupports gut lining integrity, may help with inflammatory bowel conditions, and protects against NSAID-induced damage.
Anti-Inflammatory Effects
Moderate EvidenceReduces inflammation markers and may help modulate the inflammatory response in various tissues.
Joint Health Support
Moderate EvidenceMay promote healing of damaged cartilage and support overall joint function and mobility.
Neuroprotective Properties
Emerging ResearchResearch suggests potential benefits for nerve healing and protection against certain neurotoxic compounds.
Dosage Guidelines
Disclaimer: This content is for educational purposes only. Peptides are research compounds not approved by the FDA for human use. Always consult with a qualified healthcare provider.
Can be administered orally or via subcutaneous injection. Oral bioavailability is debated but supported by some research.
Side Effects & Safety
- Generally well-tolerated in research settings
- Rare reports of nausea at higher doses
- Potential for injection site reactions
- Limited long-term safety data in humans
Frequently Asked Questions
References
- Sikiric P, et al. "Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model." European Journal of Pharmacology, 2018. PMID: 29655969
- Seiwerth S, et al. "Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease." Current Pharmaceutical Design, 2018. PMID: 29737246
- Sikiric P, et al. "BPC 157 and healing." Journal of Physiology Paris, 2019. PMID: 31234890
Get the Complete BPC-157 Research Protocol
Join 50,000+ researchers with instant access to our comprehensive peptide resource.